In 1997, Zhang et al[73] discovered the mutation of the LBD domain of ESR1 gene for the first time in metastatic breast cancer samples, and proved that this mutant has continuous transcription activity independent of estrogen. The gene discussed is ESR1; the disease is breast carcinoma.